Eli Lilly's next-generation obesity drug retatrutide helped significantly reduce A1C levels for people with diabetes while helping them lose weight.

Should A1c remain the gold standard for routine monitoring of glucose control in people with diabetes, or is it time to shift ...

The first-in-class injectable could be the next big thing in diabetes and obesity treatment.

Retatrutide is an investigational once-weekly triple hormone (glucose-dependent insulinotropic polypeptide, glucagon-like peptide-1, and glucagon) receptor agonist.

This common blood test indicates whether or not your body has been coping well with sugar over the last few months.

Tirzepatide provided a larger reduction in HbA1c and greater improvements in multiple cardiometabolic parameters compared with conventional care for adults recently diagnosed with type 2 diabetes, ...

Add Yahoo as a preferred source to see more of our stories on Google. Most people should get screened for type 2 diabetes when they turn 35 and then every three years if their test is normal, says ...

Diabetes is typically diagnosed through tests that measure blood sugar levels, with HbA1c and fasting plasma glucose (FPG) being the most common.

Eli Lilly’s experimental weight-loss drug retatrutide met the primary and key secondary endpoints in a trial, showing significant reductions in weight loss and blood sugar levels.

Please provide your email address to receive an email when new articles are posted on . HbA1c results ranged from 4.2% to 6.1% among children with asthma. 28 of 128 children with asthma had HbA1c at ...

Lowering your A1C can significantly reduce your risk of heart disease. You can lower your A1C by eating more fiber and protein, cutting back on refined carbs, and more.